That’s more than what Novo Nordisk made from Ozempic in 2024, and more than double the sales of Lilly’s own diabetes drug Mounjaro. The key difference? Orforglipron is a pill and not an injection, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback